ARCHIVES

FDA Approves Votrient For Renal Cell Carcinoma

This article is from The Cancer Letter archive.

Vol. 35 No. 39 | October 23, 2009

Download PDF Visit The Full Archive

Related Articles

In Brief: David Nathan receives Lifetime Impact Award from Boston Children’s Hospital

November 7, 2014

Research Funding: 30 Groups Sign Letter For Double NCI Budget

January 23, 1998

ACS Journal Cancer Refers I-ELCAP Studies to Office of Human Research Protections

January 6, 2012

Hematologic Malignancies: ASCO Meeting Highlights New Approaches To Treatment

July 30, 2004

Oral Sorafenib Trial Published in The Lancet; Tablets Extend PFS in Metastatic Disease

April 25, 2014

Includes May issue of Business & Regulatory Report.

May 31, 2002